Post Content
The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo Therapeutics LLC, a late-stage preclinical biopharmaceutical company focused on developing treatments for obesity and related metabolic disorders, recently presented findings from two studies at The Obesity Society’s annual meeting in San Antonio. The studies were designed to evaluate the...
Tech giants and industrials lead as Tesla takes a dip The US stock market today offers a mixed bag of performances, with major tech players showing resilience, contrasted by notable losses in the auto manufacturing sector. Investors are navigating this patchwork of fortunes with keen attention to sector dynamics and broader market trends. 📈 Technology...
The atmosphere, a thin veil of molecules enveloping Earth, reaches about 20 miles (32 kilometers) above the planet’s surface. It contains countless air particles, invisible to the naked eye, yet essential for life. Beyond this protective layer lies space, an expanse so vast it defies imagination, where molecules are sparse...
A significant portion of children under the age of 13 in the United States are actively using social media platforms like TikTok, Instagram, and Snapchat, despite clear age restrictions, according to a new study published in Academic Pediatrics. Researchers found that a majority of 11-to-15-year-olds had at least one social...
Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by 2040. This progressive eye disorder results from fluid buildup, increasing intraocular pressure (IOP) and damaging the optic nerve. While treatments to lower IOP exist, they do not halt disease progression for...
